A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MF / mycosis fungoides

[Related PubMed/MEDLINE]
Total Number of Papers: 1476
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MF  (>> Co-occurring Abbreviation)
Long Form:   mycosis fungoides
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A prospective cohort study of Condensed low dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life. QOL, TSEBT
2020 A retrospective review of cutaneous lymphoma in Botswana. ALI, PCL
2020 Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-kappaB and nuclear factor of activated T cells pathways. CTCL, JAK, NF-kappaB, STAT, TCR
2020 Another window into tumor microenvironment: a case of Beta-cell rich folliculotropic mycosis fungoides responding to rituximab. ---
2020 C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment. CCR4, CTCLs, GDTCL, LPDs, SPTCL
2020 CD8+ cytotoxic mycosis fungoides: a retrospective analysis of clinical features and follow-up results of 29 patients. ---
2020 Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. CI, HRQoL, OR, SS
2020 Concurrent mycosis fungoides and intravascular large B-cell lymphoma in a single patient. IVLBCL
2020 Cutaneous lymphoma in Japan, 2012-2017: A nationwide study. CL, NK
10  2020 Exploratory Assessment of Oxygen Flow-Assisted Cutaneous Administration ofMethotrexate for Superficial Basal CellCarcinoma, Mycosis Fungoides, andExtramammary Paget Disease. MTX
11  2020 Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis. ALCL, HM, LyP
12  2020 Histopathologic features distinguishing secondary syphilis from its mimickers. PL, PR
13  2020 Impact of narrow-band ultraviolet B phototherapy on remission and relapses of mycosis fungoides in patients with Fitzpatrick skin III-IV. nbUVB
14  2020 Interleukin-33 polymorphisms and serum concentrations in mycosis fungoides. IL-33, SNPs
15  2020 Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome. DOR, PFS, SS, TSEBT
16  2020 Lymphoprolipherative skin reactions induced by anti-TNFalpha: an open question. ---
17  2020 Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management. ---
18  2020 Mycosis Fungoides, Lymphomatoid Papulosis and Hodgkin's Lymphoma in the Same Patient: Apropos of a Possible Monoclonal Origin. HL, LyP
19  2020 Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides. LPD, LyP, NM
20  2020 Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review. CBCLs, CLs, CTCLs, SS
21  2020 Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sezary syndrome. HSCT, OS, PFS, SS
22  2020 Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study. SS
23  2020 Phototherapy for Cutaneous T-Cell Lymphoma. NB-UVB, PUVA
24  2020 Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin. ---
25  2020 Reflectance confocal microscopy may be included as part of the diagnostic algorithm of early-stage mycosis fungoides. RCM
26  2020 Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome? ---
27  2020 The different faces of mycosis fungoides: results of a single-center study. FMF
28  2020 [LINEAR MYCOSIS FUNGOIDES IN A BLASCHKOID DISTRIBUTION]. ---
29  2019 A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides. HS
30  2019 A unique case of borderline lepromatous leprosy with psoriasis-like lesions all over the body and mycosis fungoides-like lesions on the face. BL, MDT-MB
31  2019 alphaEbeta7 Expression Increases With the Extent of Cutaneous Involvement in Mycosis Fungoides. UNIFESP
32  2019 An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature. CTCL
33  2019 Antibody-Based Therapies for Cutaneous T-Cell Lymphoma. CCR4, CD, CTCLs, LyP, pcALCL, SS
34  2019 Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. CTCL, PUVA
35  2019 CCL21 Induces mTOR-dependent MALAT1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma. CCR7, HOTAIR, HULC, LUNAR1, MALAT1, mTOR
36  2019 CD30-Positive Lymphoproliferative Disorders. CTCL, LyP, pcALCL, TNF
37  2019 Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy) treatment schedule. CTCL, SS, TSEB, TSEB
38  2019 Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sezary syndrome: comparison of generic and dermatology-specific instruments. HUI3, QOL, SS, VAS itch
39  2019 Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. TCR, WES
40  2019 Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center. AD, HLD, HT
41  2019 Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. NB-UVB, OR, PRISMA, PUVA
42  2019 Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma. CTCL, SS
43  2019 Cutaneous T-Cell Acute Lymphoblastic Leukemia and the Expression Pattern of Terminal Deoxynucleotidyl Transferase Immunostaining in Mycosis Fungoides and Spongiotic Dermatitis. T-ALL, TdT
44  2019 Cutaneous T-Cell Lymphoma: Optimizing Care in Patients Receiving Anti-CCR4 Monoclonal Antibody Mogamulizumab. CTCL, SS
45  2019 Cyclooxygenase-2 Gene Polymorphisms -765G>C and -1195A>G and Mycosis Fungoides Risk. COX-2
46  2019 Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro. ROS, SS
47  2019 Dramatic response to brentuximab vedotin in refractory nontransformed CD30- mycosis fungoides allowing allogeneic stem cell transplant and long-term complete remission. BV, CHOP
48  2019 Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report. ---
49  2019 Effectiveness of brentuximab vedotin before and after allogeneic stem-cell transplantation in the management of transformed mycosis fungoides. BV
50  2019 Epidemiology and prognostic factors for mycosis fungoides and Sezary syndrome in a multi-ethnic Asian cohort: a 12-year review. SS
51  2019 Erythema gyratum Repens-like eruption in Sezary syndrome: evidence for the role of a dermatophyte. CTCL, EGR, SS
52  2019 Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma. CTCL, SS
53  2019 Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis. CTCL, KCNA3, SS
54  2019 Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study. CTCL, FM
55  2019 Hyperpigmented Mycosis Fungoides - A Rare Entity. CT
56  2019 Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sezary syndrome (SS). CTCL, SS
57  2019 Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments. CTCLs, SS
58  2019 Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin. ALCL
59  2019 Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis. CI, SIRs
60  2019 Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. ---
61  2019 Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement. SCT
62  2019 Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides. cdTSE, SS, TSE, TTNT
63  2019 Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sezary syndrome. E-MF, SS
64  2019 Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. ICI, irAEs, LD-ICI
65  2019 Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States. CE, LYs, NB-UVB, PUVA
66  2019 Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel. CTCLs, MF-CTCL
67  2019 Measurement of Quality of Life in Patients with Mycosis Fungoides/Sezary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument. QOL, SS
68  2019 Mechanisms of itching in mycosis fungoides: grade of itching correlates with eosinophil infiltration and kallikrein 5 expression. CTCL, KLK5
69  2019 Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. CCR4, FDA, SS
70  2019 Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma. CTCL, DEGs, RNA-Seq, SS, TOX
71  2019 Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. AUC, CR, mSWAT, PR, TSEBT
72  2019 Multiple melanocytic nevi restricted to mycosis fungoides patches in pediatric and young-adult patients. The potential role of local immunosuppression. ---
73  2019 Mycosis fungoides and Sezary syndrome: 2019 update on diagnosis, risk-stratification, and management. CTCL, HDAC, SS, TNMB
74  2019 Mycosis Fungoides and Sezary Syndrome: An Update. SS
75  2019 Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas? LyP, pc CD30 LPD
76  2019 Mycosis Fungoides in Children and Adolescents: A Series of 23 Cases. ---
77  2019 Mycosis fungoides with spongiosis: A potential diagnostic pitfall. ---
78  2019 Mycosis fungoides: A great imitator. ---
79  2019 Mycosis Fungoides: Analysis of Ophthalmologic Findings in a Series of Cases. ---
80  2019 Naive/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification. SS
81  2019 Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma. TCR
82  2019 Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sezary Syndrome. SS
83  2019 Oral Mycosis Fungoides: A Report of Three Cases and Review of the Literature. ---
84  2019 Papular Mycosis Fungoides Is a Distinctive Variant of Early-stage Mycosis Fungoides: Extended Retrospective Study With Long-term Follow-up. PMF
85  2019 Photo-photochemotherapy in Juvenile-onset Mycosis Fungoides: A Retrospective Study on 9 Patients. ---
86  2019 Pityriasis Lichenoid-like Mycosis Fungoides in a 9-year-old Boy: A Case Report. NB-UVB, PL, TCR-GRA
87  2019 Plasmacytoid dendritic cells in granulomatous variant of mycosis fungoides. pDCs
88  2019 Poikilodermatous Mycosis Fungoides with Erosive Lesions. ---
89  2019 Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides. DFS, NB-UVB
90  2019 Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients. miR-16, miR-93
91  2019 Prevalence of atopy and staphylococcal superantigen-specific immunoglobulin E (IgE) antibodies and total serum IgE in primary cutaneous T- and B-cell lymphoma. IgE, pcFCL, PCMZL, SS
92  2019 Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients. CBCL, CTCL, EORTC, PCL, SS, WHO
93  2019 Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma. CTCL
94  2019 Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR. TILs
95  2019 PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study. CTCL, PLC, PUVA
96  2019 Racial Disparities in the Clinical Presentation and Prognosis of Patients with Mycosis Fungoides. BSA
97  2019 Radiation therapy in mycosis fungoid patient. CRP
98  2019 Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work? CR, OR, RARs, RXRs
99  2019 Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature. FMF
100  2019 Risk of mycosis fungoides in psoriatic patients: a critical review. NHL